Birdwatch Note Rating
2023-11-08 06:29:26 UTC - NOT_HELPFUL
Rated by Participant: EEDDF85F32207F3EFE9E80296C559602682BAEA41F6F6FA5009DE02F28445137
Participant Details
Original Note:
This info is outdated & inaccurate. Following publication of new data looking at Remdesivir effects on hospitalization the WHO updated guidance. WHO now suggests the use of remdesivir in mild or moderate COVID-19 patients who are at high risk of hospitalization https://www.who.int/news/item/22-04-2022-who-recommends-highly-successful-covid-19-therapy-and-calls-for-wide-geographical-distribution-and-transparency-from-originator
All Note Details